Followers | 131 |
Posts | 29747 |
Boards Moderated | 0 |
Alias Born | 12/21/2008 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, July 13, 2012 4:47:24 PM
To consider for election six individuals to the Company’s Board of Directors
Under plurality voting, the six nominees who received the most “FOR” votes were elected as directors. The Company’s stockholders elected the Board of Director’s six nominees: Anthony Atala, M.D.; Harold Berger; David Portnoy; Mark Portnoy; George Gaines; and Jonathan Wheeler, M.D. as directors, each for a one-year term, as follows:
Anthony Atala, M.D.
For
4,989,956
Withhold
12,607
Broker non-votes
—
Harold Berger
For
4,989,956
Withhold
12,607
Broker non-votes
—
George Gaines
For
4,989,956
Withhold
12,607
Broker non-votes
—
David I. Portnoy
For
4,989,956
Withhold
12,607
Broker non-votes
—
Mark L. Portnoy
For
4,989,656
Withhold
12,607
Broker non-votes
—
--------------------------------------------------------------------------------
Jonathan H. Wheeler, M.D.
For
4,989,956
Withhold
12,607
Broker non-votes
—
The stockholders did not approve the election of the following nominees:
Ajay Badlani
For
3,017,045
Withhold
11,615
Broker non-votes
—
Ki Yong Choi
For
3,018,419
Withhold
10,241
Broker non-votes
—
Michael W. Cho
For
3,017,045
Withhold
11,615
Broker non-votes
—
Michael D. Coffee
For
3,022,195
Withhold
6,465
Broker non-votes
—
Warren Hoeffler
For
3,023,195
Withhold
5,465
Broker non-votes
—
Gary D. Weinhouse
For
3,022,069
Withhold
6,591
Broker non-votes
—
--------------------------------------------------------------------------------
2.
The ratification of the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending November 30, 2012.
For
Against
Abstain
Broker Non-Vote
7,484,861
550,722
5,200
—
3.
The approval of the Company’s 2012 Equity Incentive Plan.
For
Against
Abstain
Broker Non-Vote
4,890,109
3,107,964
33,150
—
Item 9.01 Financial Statements and Exhibits
Not Applicable.
--------------------------------------------------------------------------------
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Cryo-Cell International, Inc.
DATE: July 13, 2012
By:
/s/ David I. Portnoy
David I. Portnoy,
Chairman and Co-Chief Executive Officer
My attitude with penny stocks is similar to Vegas - I don't use any funds I'm not prepared to totally lose.
Not to say I don't try very hard to "win", but it minimizes the stress of sudden movements.
Recent CCEL News
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results • Business Wire • 04/15/2024 09:00:00 PM
- Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value • Business Wire • 03/25/2024 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/28/2024 10:20:13 PM
- Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023 • Business Wire • 02/28/2024 10:00:00 PM
- Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET • GlobeNewswire Inc. • 01/22/2024 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:00:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:00:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/12/2023 09:01:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 09:00:21 PM
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results • Business Wire • 10/12/2023 08:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 08:30:34 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 09/15/2023 03:30:08 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/14/2023 08:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/25/2023 08:17:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/14/2023 09:11:16 PM
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results • Business Wire • 07/14/2023 08:15:00 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM